SCHEMBL7608510

SCHEMBL7608510

CC/C(CCc1ccccc1)=N\O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.48
KEAP1 Q14145 1/20 0.47
FFAR1 O14842 2/20 0.44
GRIN1 Q05586 1/20 0.43
GRIN2B Q13224 1/20 0.43
TDP1 Q9NUW8 3/20 0.41
HDAC2 Q92769 2/20 0.41
HDAC8 Q9BY41 2/20 0.41
HDAC6 Q9UBN7 2/20 0.41
KDM4E B2RXH2 1/20 0.41
RECQL P46063 1/20 0.41
KMT2A Q03164 1/20 0.41
HPGD P15428 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
HDAC3 O15379 2/20 0.39
MAPK1 P28482 1/20 0.39
ADRA1A P35348 1/20 0.39
HDAC4 P56524 1/20 0.39
SLC6A3 Q01959 1/20 0.39
HDAC1 Q13547 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7608511 1.00 ALDH1A1 (0.48) ALDH1A1KEAP1FFAR1GRIN1GRIN2B
SCHEMBL7280063 0.87 KEAP1 (0.54) ALDH1A1KEAP1FFAR1GRIN1GRIN2B
SCHEMBL11435918 0.82 KEAP1 (0.48) ALDH1A1KEAP1FFAR1GRIN1GRIN2B
SCHEMBL10749652 0.80 GRIN1 (0.47) ALDH1A1KEAP1FFAR1GRIN1GRIN2B
SCHEMBL10749659 0.80 GRIN1 (0.47) ALDH1A1KEAP1FFAR1GRIN1GRIN2B
SCHEMBL5604545 0.79 CTBP2 (0.48) ALDH1A1KDM4EKMT2AMAPK1SMN1; SMN2
SCHEMBL5604550 0.79 CTBP2 (0.48) ALDH1A1KDM4EKMT2AMAPK1SMN1; SMN2
SCHEMBL14423596 0.77 KEAP1 (0.64) ALDH1A1KEAP1FFAR1TDP1HDAC2
SCHEMBL5348465 0.77 KEAP1 (0.64) ALDH1A1KEAP1FFAR1TDP1HDAC2
SCHEMBL5348463 0.77 KEAP1 (0.64) ALDH1A1KEAP1FFAR1TDP1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6403794-B2 REACTING A BIGUANIDINE WITH AN ALKOXYCARBONYL, OR A SUBSTITUTED TRIAZINE WITH AMMONIA OR AN ALKYLAMINE BAYER AKTIENGESELLSCHAFT (DE) 2002-06-11 US disclosed
US-6346503-B1 PRE- AND POSTEMERGENCE HERBICIDES FOR CROPS LIKE CORN, WHEAT, AND COTTON BAYER AKTIENGESELLSCHAFT (DE) 2002-02-12 US disclosed
US-20020016459-A1 Substituted 2-amino-4-alkylamino-1,3,5-triazines as herbicides RIEBEL HANS-JOCHEM (DE) 2002-02-07 US disclosed
EP-0934284-A1 SUBSTITUTED 2-AMINO-4-ALKYLAMINO-1,3,5-TRIAZINES AS HERBICIDES BAYER AG (DE) 1999-08-11 EP disclosed
WO-1998015537-A1 SUBSTITUTED 2-AMINO-4-ALKYLAMINO-1,3,5-TRIAZINES AS HERBICIDES BAYER AKTIENGESELLSCHAFT (DE) 1998-04-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020016459-A1 Substituted 2-amino-4-alkylamino-1,3,5-triazines as herbicides AHR, DDT, CYP1A1 ALDH1A1 129/4885KEAP1 314/4885FFAR1 1520/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.